18F-FDG PET/CT detects clinical vulnerability in carotid atherosclerotic plaques

Kjersti Johnsrud aimed to find out if positron emission tomography (PET) with radiolabelled glucose (18F-FDG) is a reliable imaging modality to detect vulnerable atherosclerotic plaques.


MAIN RESULTS:

  1. 18F-FDG PET/CT can detect inflammation and clinical vulnerability in large carotid atherosclerotic plaques.
  2. Quantification methods for 18F-FDG PET uptake in carotid artery plaque inflammation correlate with inflammation status.

THESIS DEFENCE:

Thesis: 18F-FDG PET imaging of atherosclerotic carotid stenosis
Candidate: Kjersti Johnsrud
Time: November 26, 2020 at 12:15
Place: Online-based solution, due to the covid-19 situation
Link to university website


SUMMARY:

(3) Symptomatic patients referred to surgical treatment for severe atherosclerotic carotid stenosis have higher carotid plaque uptake of 18F-FDG than asymptomatic patients. Uptake correlates significantly with inflammation.

(1/2) Several different methods for quantification of 18F-FDG uptake in carotid atherosclerotic plaques correlate well with each other and with  histological assessments of inflammation. Moreover, inter-reader variability of the different methods is low.

These studies include analyses from 43 patients with carotid artery stenosis ≥70%, and 30 plaques were assessed histologically following endarterectomy.


REFERENCES:

(1) Johnsrud, K., Skagen, K., Seierstad, T., Skjelland, M., Russell, D., & Revheim, M. E. (2019). 18 F-FDG PET/CT for the quantification of inflammation in large carotid artery plaquesJournal of Nuclear Cardiology26(3), 883-893.

(2) Johnsrud, K., Seierstad, T., Russell, D., & Revheim, M. E. (2019). Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammation. bioRxiv, 807420.

Norheart uses cookies for analytical purposes, content and ads customisation, and to further develop our services.
Accept
Learn more
Show again